Patents by Inventor Kumaresan Parthasarathi

Kumaresan Parthasarathi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240398760
    Abstract: This invention provides novel compositions comprising an anti-inflammatory agent and a mydriatic agent suitable for intraocular use, particularly ketorolac or pharmaceutically salts thereof and phenylephrine or pharmaceutically salts thereof, which are free of any buffering agent and yet, surprisingly, maintain stability for significant periods of time (e.g., at least about 3 months). The present invention also relates to a process of preparing such compositions and use thereof, e.g., in combination with intraocular ophthalmologic irrigation solutions.
    Type: Application
    Filed: May 23, 2024
    Publication date: December 5, 2024
    Inventors: MANDAR V. SHAH, KUMARESAN PARTHASARATHI, ILANGO SUBRAMANIAN, VEERAPPAN SUBRAMANIAN, AMAN TREHAN
  • Patent number: 12029729
    Abstract: This invention provides novel compositions comprising an anti-inflammatory agent and a mydriatic agent suitable for intraocular use, particularly ketorolac or pharmaceutically salts thereof and phenylephrine or pharmaceutically salts thereof, which are free of any buffering agent and yet, surprisingly, maintain stability for significant periods of time (e.g., at least about 3 months). The present invention also relates to a process of preparing such compositions and use thereof, e.g., in combination with intraocular ophthalmologic irrigation solutions.
    Type: Grant
    Filed: July 23, 2022
    Date of Patent: July 9, 2024
    Assignee: Somerset Therapeutics, LLC
    Inventors: Mandar V. Shah, Kumaresan Parthasarathi, Ilango Subramanian, Veerappan Subramanian, Aman Trehan
  • Patent number: 11883382
    Abstract: This invention provides novel compositions comprising an anti-inflammatory agent and a mydriatic agent suitable for intraocular use, particularly ketorolac or pharmaceutically salts thereof and phenylephrine or pharmaceutically salts thereof, which are free of any buffering agent and yet, surprisingly, maintain stability for significant periods of time (e.g., at least about 3 months). The present invention also relates to a process of preparing such compositions and use thereof, e.g., in combination with intraocular ophthalmologic irrigation solutions.
    Type: Grant
    Filed: July 23, 2022
    Date of Patent: January 30, 2024
    Assignee: Somerset Therapeutics, LLC
    Inventors: Mandar V. Shah, Kumaresan Parthasarathi, Ilango Subramanian, Veerappan Subramanian, Aman Trehan
  • Patent number: 11793789
    Abstract: This invention provides novel compositions comprising an anti-inflammatory agent and a mydriatic agent suitable for intraocular use, particularly ketorolac or pharmaceutically salts thereof and phenylephrine or pharmaceutically salts thereof, which are free of any buffering agent and yet, surprisingly, maintain stability for significant periods of time (e.g., at least about 3 months). The present invention also relates to a process of preparing such compositions and use thereof, e.g., in combination with intraocular ophthalmologic irrigation solutions.
    Type: Grant
    Filed: July 23, 2022
    Date of Patent: October 24, 2023
    Assignee: Somerset Therapeutics, LLC
    Inventors: Mandar V. Shah, Kumaresan Parthasarathi, Ilango Subramanian, Veerappan Subramanian, Aman Trehan
  • Patent number: 11696910
    Abstract: This invention provides novel compositions comprising an anti-inflammatory agent and a mydriatic agent suitable for intraocular use, particularly ketorolac or pharmaceutically salts thereof and phenylephrine or pharmaceutically salts thereof, which are free of any buffering agent and yet, surprisingly, maintain stability for significant periods of time (e.g., at least about 3 months). The present invention also relates to a process of preparing such compositions and use thereof, e.g., in combination with intraocular ophthalmologic irrigation solutions.
    Type: Grant
    Filed: July 23, 2022
    Date of Patent: July 11, 2023
    Assignee: Somerset Therapeutics, LLC
    Inventors: Mandar V. Shah, Kumaresan Parthasarathi, Ilango Subramanian, Veerappan Subramanian, Aman Trehan
  • Publication number: 20230042072
    Abstract: This invention provides novel compositions comprising an anti-inflammatory agent and a mydriatic agent suitable for intraocular use, particularly ketorolac or pharmaceutically salts thereof and phenylephrine or pharmaceutically salts thereof, which are free of any buffering agent and yet, surprisingly, maintain stability for significant periods of time (e.g., at least about 3 months). The present invention also relates to a process of preparing such compositions and use thereof, e.g., in combination with intraocular ophthalmologic irrigation solutions.
    Type: Application
    Filed: July 23, 2022
    Publication date: February 9, 2023
    Inventors: Mandar V. Shah, Kumaresan Parthasarathi, Ilango Subramanian, Veerappan Subramanian, Aman Trehan
  • Publication number: 20230044398
    Abstract: This invention provides novel compositions comprising an anti-inflammatory agent and a mydriatic agent suitable for intraocular use, particularly ketorolac or pharmaceutically salts thereof and phenylephrine or pharmaceutically salts thereof, which are free of any buffering agent and yet, surprisingly, maintain stability for significant periods of time (e.g., at least about 3 months). The present invention also relates to a process of preparing such compositions and use thereof, e.g., in combination with intraocular ophthalmologic irrigation solutions.
    Type: Application
    Filed: July 23, 2022
    Publication date: February 9, 2023
    Inventors: Mandar V. Shah, Kumaresan Parthasarathi, Ilango Subramanian, Veerappan Subramanian, Aman Trehan
  • Publication number: 20230039551
    Abstract: This invention provides novel compositions comprising an anti-inflammatory agent and a mydriatic agent suitable for intraocular use, particularly ketorolac or pharmaceutically salts thereof and phenylephrine or pharmaceutically salts thereof, which are free of any buffering agent and yet, surprisingly, maintain stability for significant periods of time (e.g., at least about 3 months). The present invention also relates to a process of preparing such compositions and use thereof, e.g., in combination with intraocular ophthalmologic irrigation solutions.
    Type: Application
    Filed: July 23, 2022
    Publication date: February 9, 2023
    Inventors: Mandar V. Shah, Kumaresan Parthasarathi, Ilango Subramanian, Veerappan Subramanian, Aman Trehan
  • Publication number: 20230040977
    Abstract: This invention provides novel compositions comprising an anti-inflammatory agent and a mydriatic agent suitable for intraocular use, particularly ketorolac or pharmaceutically salts thereof and phenylephrine or pharmaceutically salts thereof, which are free of any buffering agent and yet, surprisingly, maintain stability for significant periods of time (e.g., at least about 3 months). The present invention also relates to a process of preparing such compositions and use thereof, e.g., in combination with intraocular ophthalmologic irrigation solutions.
    Type: Application
    Filed: July 23, 2022
    Publication date: February 9, 2023
    Inventors: Mandar V. Shah, Kumaresan Parthasarathi, Ilango Subramanian, Veerappan Subramanian, Aman Trehan
  • Publication number: 20230026943
    Abstract: This invention provides novel compositions comprising an anti-inflammatory agent and a mydriatic agent suitable for intraocular use, particularly ketorolac or pharmaceutically salts thereof and phenylephrine or pharmaceutically salts thereof, which are free of any buffering agent and yet, surprisingly, maintain stability for significant periods of time (e.g., at least about 3 months). The present invention also relates to a process of preparing such compositions and use thereof, e.g., in combination with intraocular ophthalmologic irrigation solutions.
    Type: Application
    Filed: July 23, 2022
    Publication date: January 26, 2023
    Inventors: Mandar V. Shah, Kumaresan Parthasarathi, Ilango Subramanian, Veerappan Subramanian, Aman Trehan